| 摘要 |
The invention relates to novel compounds of formula (I), wherein: D, E, Q, T, X, Y, Z, Z', R1, R 4, and R4'have the meanings cited in Claim 1. These novel compounds are inhibitors of coagulation factor Xa and can be used for the prophylaxis and/or the treatment of thromboembolic diseases and for treating tumors.
|
